
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Mark Cuban shakes up pharmacy pricing
Mark Cuban is best known for business and basketball, but lately, his passion has been shaking up the pharmaceutical world by showing the wholesale costs of many generic drugs and an independent pharmacist from Minnesota was among those he consulted with for wholesale pricing.

Legalized Racketeering? How PBMs Skirt the Law to Rake in Billions
Pharmacy Benefit Managers (PBMs) have been under scrutiny lately for their actions as middlemen in the flow of prescription drugs from manufacturers to patients. But perhaps their worst actions are buried within a maze of consolidation and paperwork. Big Insurance has consolidated the entire pharmaceutical benefit, claim, and dispensing sector to squeeze as much money out of patients as possible.

The Opaque Industry Secretly Inflating Prices for Prescription Drugs
Pharmacy Benefit Managers (PBMs) are driving up drug costs for millions of people, employers and the government.
The second in “THE MIDDLEMEN” series of articles by reporters Rebecca Robins and Reed Abelson investigating PBMs.
Under threat from industry ‘middlemen,’ independent pharmacies gain allies in D.C., Frankfort
Kentucky Gov. Andy Beshear joined a White House roundtable discussion on prescription drug costs that also featured entrepreneur Mark Cuban and several community pharmacists from around the country.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.